Mary Kay Ash Foundation (MKAF)

2024-2025 Mary Kay Ash Foundation® Innovative/Translational Cancer Research Grant

Institutionally Coordinated // Limit: 1 // Available: 0

M. Herbst-Kralovetz (Cancer Center)

The submission for this funding program is coordinated by the University of Arizona Cancer Center.Please contact UACC Pre Award for more information.

The Mary Kay Ash Foundation®, a funding source for cancer research, is currently accepting applications for innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian, uterine or cancers predominantly affecting women. 

Award Amount

The grant period is two years beginning September 1, 2025 – September 1, 2027*. Contracts are distributed to the final awardees in early June. 

Eligibility 

  • The Principal Investigator must be a full-time assistant professor or higher at the time of application submission and commit a minimum 5% effort. Pending future appointments will not be honored.
  • U.S. citizenship is not required.
  • One Co-PI is permitted and must meet the same eligibility requirements as the PI. International Co-PIs are permitted with the caveat that all funds will be designated to the U.S.-based university. Post-doc contributors must be listed as co-investigators, not PIs.

Budget

  • The total budget over two years may not exceed $100,000 (combined indirect/direct costs).
  • The budget should follow the NIH format for a two-year grant ($50,000/year) and include justification.
  • The NIH salary cap of $199.300 must be followed
  • Indirect costs must not exceed 15% of direct costs .

Allowable Activities and Expenses

  • Animal studies are allowed. However, researchers will need to indicate how their studies would impact patient care in the future should their research be successful.
  • Equipment and travel costs must be justified

     

Application Requirements

A complete application must include the following:

  • Research Description (6 pages max)
  • Literature References Cited (2 pages max)
  • Letters of Collaboration/Letters of Support (3 pages max)
  • Current Financial Support (2 pages max)
  • NIH-format Budget & Justification
  • NIH-format Bio sketch or equivalent (5 pages max)
  • If a co-PI or additional collaborators are included in your research team, please provide a brief resume for each.
  • Preliminary data is not required, however it is helpful to include if available

 

Funding Type
Internal Deadline
External Deadline
2/1/2025
Solicitation Type

Mary Kay Ash Foundation (MKAF): 2024 Innovative/Translational Cancer Research Grant

Limit: 1 // PI: G. Sutphin (Molecular and Cellular Biology)

The University of Arizona Cancer Center (UACC) coordinates the internal selection process for this funding program, for more information please contact UACC-PreAward.

MKAF is currently accepting applications for innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian, uterine or cancers predominantly affecting women. Grants will be awarded in the amount of $100,000 over a two- year period. PI must commit a minimum 5% effort.

Funding Type
Internal Deadline
External Deadline
02/01/2024
Solicitation Type